Key Takeaways
- • Rohan Dutt, Managing Director of Global Secondaries at Cambridge Associates, says GP-led transactions could rise to roughly 60% of annual secondaries volume from about 45-50% today, in a market he projects could reach $400-500 billion annually.
- • Dutt says the secondaries market has moved through three eras, from a sub-$10B distressed niche before 2006, to mainstream growth reaching about $162B in volume in 2024, to today's institutionalized market where GP-led continuation vehicles are reshaping exit strategies.
- • Dutt identifies deep GP relationships and disciplined pricing and pacing as the key sources of sustainable alpha, and warns that growing funds risk overpaying to deploy capital.
- • Dutt flags alignment as the central test for continuation vehicles, citing GP rollover of meaningful economics as a signal of conviction and a failed sale process as a red flag.
- • Dutt identifies a senior talent shortage and a capital gap in the GP-led segment, which he says has 1.5-2 years of dry powder for secondaries overall but is "even more undercapitalized."
Summary
Rohan Dutt, Managing Director of Global Secondaries at Cambridge Associates, outlined the evolution and outlook for the secondaries market in a recent ION Influencers fireside chat, according to ION Analytics. Drawing on 15 years of experience, Dutt framed secondaries as a core, strategic asset class rather than a niche tactic, driven by portfolio management needs and a reshaping of private market liquidity.
Dutt described three phases of market development. The distressed era before 2006 featured a small, fragmented market with volume below $10B, where secondaries were a last resort for sellers in financial difficulty and were often blocked by wary GPs. The mainstreaming era from 2006 through the 2020s saw volume grow to about $162B in 2024, as LPs began using secondaries for active portfolio management. The current phase is defined by institutionalization and the rise of GP-led transactions, which now account for roughly 45-50% of volume.
Looking ahead, Dutt aligned with industry projections of a $400-500 billion annual market. He predicted GP-led deals could soon represent 60% of annual volume, and noted that GPs are planning continuation vehicles earlier in a fund's life. He characterized this as a way to hold top-performing trophy assets longer, and advised LPs to assess whether a CV is the best exit path or simply the most convenient for GP economics.
On sources of alpha, Dutt emphasized access to GP relationships, noting that GPs are becoming more restrictive about which secondary buyers they approve. He said pricing and pacing discipline is the key differentiator, warning that growing funds may overpay or compromise strategy to deploy capital. Cambridge Associates, he said, uses extensive referencing with GPs to distinguish strategic relationships from transactional ones.
Dutt set out alignment tests for continuation vehicles. For single-asset CVs, he cited a credible upside thesis and meaningful GP rollover as signals of conviction, and flagged a CV following a failed sale process as a potential sign that the GP is prioritizing carry. For multi-asset CVs, he cautioned that some are primarily DPI exercises providing liquidity to existing LPs, and that repeat CVs from the same fund warrant scrutiny.
Dutt also identified constraints on growth, including a senior talent shortage as platforms expand and senior professionals are recruited by new entrants, which makes team stability a due diligence priority. He said secondaries overall have 1.5-2 years of dry powder, but the GP-led segment is more undercapitalized, and he urged LPs to build dedicated allocations to it as more risk-adjusted buyout exposure.
Dutt described three phases of market development. The distressed era before 2006 featured a small, fragmented market with volume below $10B, where secondaries were a last resort for sellers in financial difficulty and were often blocked by wary GPs. The mainstreaming era from 2006 through the 2020s saw volume grow to about $162B in 2024, as LPs began using secondaries for active portfolio management. The current phase is defined by institutionalization and the rise of GP-led transactions, which now account for roughly 45-50% of volume.
Looking ahead, Dutt aligned with industry projections of a $400-500 billion annual market. He predicted GP-led deals could soon represent 60% of annual volume, and noted that GPs are planning continuation vehicles earlier in a fund's life. He characterized this as a way to hold top-performing trophy assets longer, and advised LPs to assess whether a CV is the best exit path or simply the most convenient for GP economics.
On sources of alpha, Dutt emphasized access to GP relationships, noting that GPs are becoming more restrictive about which secondary buyers they approve. He said pricing and pacing discipline is the key differentiator, warning that growing funds may overpay or compromise strategy to deploy capital. Cambridge Associates, he said, uses extensive referencing with GPs to distinguish strategic relationships from transactional ones.
Dutt set out alignment tests for continuation vehicles. For single-asset CVs, he cited a credible upside thesis and meaningful GP rollover as signals of conviction, and flagged a CV following a failed sale process as a potential sign that the GP is prioritizing carry. For multi-asset CVs, he cautioned that some are primarily DPI exercises providing liquidity to existing LPs, and that repeat CVs from the same fund warrant scrutiny.
Dutt also identified constraints on growth, including a senior talent shortage as platforms expand and senior professionals are recruited by new entrants, which makes team stability a due diligence priority. He said secondaries overall have 1.5-2 years of dry powder, but the GP-led segment is more undercapitalized, and he urged LPs to build dedicated allocations to it as more risk-adjusted buyout exposure.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.